Patient characteristics as effect modifiers for psoriasis biologic treatment response: an assessment using network meta-analysis subgroups

Overview of attention for article published in Systematic Reviews, June 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

twitter: 4 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 31 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

guselkumab

Cited by Canadian Agency for Drugs and Technologies in Health on 27 Feb 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

bimekizumab

Cited by Canadian Agency for Drugs and Technologies in Health on 31 May 2022

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.